Blog RSS Blog.

Ethics of the Trump Budget: The Social Contract is Dead

03/17/2017

by Craig Klugman, Ph.D.

President Trump released his blueprint for a 2018 federal budget. From an ethical standpoint, the President seems to operates from a Hobbesian standpoint—life is nasty, brutish and short. However, unlike Hobbes who believed that we came together to protect ourselves from this reality, the new budget seems to encourage this idea. The new budget makes deep cuts to all social and scientific programs while boosting the military. In Hobbesian terms, Trumps’ social contract is all about bullying outsiders while leaving insiders in a state of hopeless diffidence.…

Btn Rss Bioethics News.

03/30/2017
Gates Foundation announces open-access publishing venture Nature

One of the world’s wealthiest charities, the Bill & Melinda Gates Foundation in Seattle, Washington, is set to launch its own open-access publishing venture later this year. The initiative, Gates Open Research, was announced on 23 March and will be modelled on a service begun last year by the London-based biomedical charity, the Wellcome Trust. Like that effort, the Gates Foundation’s platform is intended to accelerate the publication of articles and data from research funded by the charity.

03/29/2017
Zika mosquito genome mapped – at last Nature

As the Zika virus raced across the Western Hemisphere in 2015 and 2016, geneticists eager to battle the outbreak felt crippled. The genome sequence of the Aedes aegypti mosquito that spreads Zika was incomplete and consisted of thousands of short DNA fragments, hampering research efforts. With help from a new technique for stitching together genome sequences, scientists have finally ‘assembled’ the genome of A. aegypti as well as that of Culex quinquefasciatus, a mosquito that transmits West Nile virus.

03/28/2017
Dying patients want easier access to experimental drugs. Experts say that’s bad medicine Watertown Daily Times

DeBartoli walks with difficulty and falls frequently. He’s losing his ability to breathe on his own. Now the 55-year-old from Tracy, Calif., has pinned his hopes on an experimental drug made by Genentech — and a new “right-to-try” law that allows desperate patients to take medications before they’ve been fully vetted by the Food and Drug Administration. The measure’s newest fan is President Donald Trump, who said the FDA’s caution in granting dying patients access to some medications had “always disturbed” him. But for all its populist appeal, the push for right-to-try laws has raised the ire of ethicists, drug safety experts and a former FDA commissioner.

03/27/2017
Molecule kills elderly cells, reduces signs of aging in mice Science

Even if you aren’t elderly, your body is home to agents of senility—frail and damaged cells that age us and promote disease. Now, researchers have developed a molecule that selectively destroys these so-called senescent cells. The compound makes old mice act and appear more youthful, providing hope that it may do the same for us.